Mediators of Inflammation / 2020 / Article / Tab 2

Research Article

The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection

Table 2

Clinicopathological variables of 206 colorectal cancer patients according to the ΔSII.

Variables
(35.9%) (64.1%)

Age (years)
 >6038 (51.4)35 (26.5)<0.001
 ≤6036 (48.6)97 (73.5)
Gender
 Male33 (44.6)75 (56.8)0.092
 Female41 (55.4)57 (43.2)
Smoking status
 Yes20 (27.0)43 (32.6)0.407
 No54 (73.0)89 (67.4)
KPS
 >8051 (68.9)97 (73.5)0.485
 ≤8023 (31.1)35 (26.5)
Localization
 Rectum46 (62.2)75 (56.8)0.455
 Colon28 (37.8)57 (43.2)
Surgical approach
 Laparoscopy42 (56.8)75 (56.8)0.993
 Open32 (43.2)57 (43.2)
Adjuvant therapy
 Yes28 (37.8)73 (35.4)0.016
 No46 (62.2)59 (64.6)
CEA (ng/ml)
 >533 (44.6)56 (42.4)0.763
 ≤541 (55.4)76 (57.6)
Pathological stage
 Stages I-II42 (56.8)67 (50.8)0.408
 Stages III-IV32 (43.2)65 (49.2)
Differentiated degree
 High-middle61 (82.4)112 (84.8)0.650
 Minor13 (17.6)20 (15.2)
Lymphatic invasion
 Yes32 (43.2)67 (50.8)0.300
 No42 (56.8)65 (49.2)
Vascular invasion
 Yes27 (36.5)72 (54.5)0.013
 No47 (63.5)60 (45.5)

KPS: ∆SII: the change in the systemic immune-inflammation index; KPS: Karnofsky Performance Status; CEA: carcinoembryonic antigen.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.